9 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Unprovoked • Active Malignancy ... #PE #Pulmonary # ... #management #hematology ... #VTE #thrombosis ... #venous
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
; PE = pulmonary ... = venous thromboembolism ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Hematology #Oncology
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Active malignancy ... #VTE #DVT #Algorithm ... #Venous #Thromboembolism ... #Treatment #Hematology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... actor for arterial thrombosis ... ) Venous thromboembolism ... #diagnosis #algorithm ... #hematology #VTE
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thromboembolic ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #management #DVT ... #hematology #length
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... Unprovoked • Active Malignancy ... #management #hematology ... #VTE #thrombosis ... #venous
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... catheter-related thrombosis ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Hematology #Oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism ... proximal DVT or PE ... therapy - Second VTE ... #management #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/PE ... • Treatment algorithms ... (if history of venous ... #diagnosis #management ... #hematology